Liver TET1 was found to promote metabolic dysfunction-associated steatotic liver disease (MASLD) by regulating CD36 ...

New research identifies the liver protein PTPRD as a key regulator of metabolic liver disease. Reduced levels of PTPRD disrupt glucose and lipid metabolism, promote liver fat accumulation, and impair ...

Patients exposed long term to organic phosphates and treated with silymarin for 1 month did not exhibit any improvement in liver function as compared with controls, although serum levels of ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated with significant global public health concerns.

Impaired lysosomal function (breaking down waste ... is the first to demonstrate how Asah1 specifically affects lipid processing in liver cells and influences disease progression." ...

Hepatic decompensation is when a person may be reaching end stage liver failure and experiences complications such as ascites ...

Mar. 24, 2025 — A comprehensive study shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both ...

“The heart just functions as a heart to pump the blood. The major function of the kidney is to produce the urine. The liver has so many functions,” Wang, a surgeon in the Department of ...

A recent study found that 80% of Indian IT professionals have fatty liver due to a sedentary lifestyle, poor diet, and work ...